Who owns Y Mabs Therapeutics Inc?
- Ticker: YMAB
- CUSIP Number: 984241109
Tip: Access positions for across all investors
Analyze quarterly positions in Y Mabs Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Y Mabs Therapeutics stock
Who bought or sold Y Mabs Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 2.9M | $47M | 16% | Mar 2024 |
|
| Paradigm Biocapital Advisors | 2.2M | $36M | 100% | Mar 2024 |
|
| Sofinnova Ventures | 2.2M | $36M | 0% | Mar 2024 |
|
| Vanguard Group | 2.1M | $34M | -8% | Mar 2024 |
|
| Point72 Asset Management | 1.5M | $25M | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 1.1M | $17M | -19% | Mar 2024 |
|
| Pictet Asset Management Holding SA | 746k | $12M | 100% | Mar 2024 |
|
| Geode Capital Management | 743k | $12M | 4% | Mar 2024 |
|
| Acadian Asset Management | 602k | $9.8M | -26% | Mar 2024 |
|
| Caligan Partners | 587k | $9.5M | -44% | Mar 2024 |
|
| Soleus Capital Management | 571k | $9.3M | 263% | Mar 2024 |
|
| Dimensional Fund Advisors | 419k | $6.8M | 34% | Mar 2024 |
|
| Goldman Sachs Group | 366k | $5.9M | -8% | Mar 2024 |
|
| Boothbay Fund Management | 347k | $5.6M | 2129% | Mar 2024 |
|
| Northern Trust | 322k | $5.2M | 0% | Mar 2024 |
|
| Millennium Management | 283k | $4.6M | 1242% | Mar 2024 |
|
| Nuveen Asset Management | 268k | $4.4M | -25% | Mar 2024 |
|
| Charles Schwab Investment Management | 250k | $4.1M | 1% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 202k | $3.3M | 19% | Mar 2024 |
|
| Morgan Stanley | 188k | $3.1M | 74% | Mar 2024 |
|
| Jacobs Levy Equity Management | 154k | $2.5M | -39% | Mar 2024 |
|
| Citadel Advisors | 150k | $2.4M | 6% | Mar 2024 |
|
| Two Sigma Advisers | 130k | $2.1M | -21% | Mar 2024 |
|
| Thomas Stevens, CFA" | 128k | $2.1M | -64% | Mar 2024 |
|
| Bank of New York Mellon | 112k | $1.8M | -7% | Mar 2024 |
|
| Two Sigma Investments | 104k | $1.7M | 69% | Mar 2024 |
|
| Jane Street | 101k | $1.6M | 211% | Mar 2024 |
|
| Rice Hall James & Associates | 86k | $1.4M | 1% | Mar 2024 |
|
| Massachusetts Financial Services | 79k | $1.3M | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 78k | $1.3M | 110% | Mar 2024 |
|
| Campbell & Co. Investment Adviser | 76k | $1.2M | 100% | Mar 2024 |
|
| Susquehanna International | 76k | $1.2M | 236% | Mar 2024 |
|
| Bridgeway Capital Management | 66k | $1.1M | -31% | Mar 2024 |
|
| Alliancebernstein | 63k | $428k | -19% | Dec 2023 |
|
| Rhumbline Advisers | 55k | $898k | 2% | Mar 2024 |
|
| Squarepoint Ops | 52k | $845k | 100% | Mar 2024 |
|
| American Century Companies | 46k | $745k | 110% | Mar 2024 |
|
| Federated Investors | 45k | $303k | 4708% | Dec 2023 |
|
| Sapient Capital | 44k | $711k | 0% | Mar 2024 |
|
| AQR Capital Management | 38k | $606k | 100% | Mar 2024 |
|
| UBS Group | 38k | $611k | 2% | Mar 2024 |
|
| Ziegler Capital Management | 36k | $577k | 100% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 35k | $570k | -55% | Mar 2024 |
|
| State of Wisconsin Investment Board | 35k | $569k | -54% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 35k | $567k | -1% | Mar 2024 |
|
| Robeco Investment Management | 34k | $556k | 100% | Mar 2024 |
|
| Franklin Resources | 33k | $537k | 110% | Mar 2024 |
|
| Jpmorgan Chase & Co | 31k | $507k | -25% | Mar 2024 |
|
| Trexquant Investment | 29k | $195k | -63% | Dec 2023 |
|
| FMR | 28k | $455k | -22% | Mar 2024 |
|
| Barclays | 26k | $418k | -49% | Mar 2024 |
|
| T. Rowe Price Associates | 21k | $345k | 8% | Mar 2024 |
|
| MetLife Investment Advisors | 20k | $137k | 0% | Dec 2023 |
|
| Exchange Traded Concepts | 19k | $309k | -32% | Mar 2024 |
|
| Caxton Associates | 19k | $306k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 19k | $303k | 0% | Mar 2024 |
|
| American International | 18k | $125k | 0% | Dec 2023 |
|
| Verition Fund Management | 17k | $270k | 100% | Mar 2024 |
|
| Hrt Financial | 16k | $263k | 100% | Mar 2024 |
|
| Point72 | 15k | $240k | 100% | Mar 2024 |
|
| Florida State Board of Administration | 14k | $72k | -2% | Mar 2024 |
|
| Principal Financial Group | 14k | $223k | -7% | Mar 2024 |
|
| Bank of America Corporation | 13k | $214k | -64% | Mar 2024 |
|
| New York State Common Retirement Fund | 13k | $205k | 102% | Mar 2024 |
|
| Ing Investment Management | 13k | $204k | -67% | Mar 2024 |
|
| Wells Fargo & Company | 12k | $195k | 15% | Mar 2024 |
|
| SG Americas Securities | 12k | $195k | -45% | Mar 2024 |
|
| China Universal Asset Management | 8.4k | $136k | 66% | Mar 2024 |
|
| Citigroup | 6.7k | $110k | 12% | Mar 2024 |
|
| Point72 Asia | 6.0k | $98k | 100% | Mar 2024 |
|
| Quantbot Technologies | 4.5k | $74k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 3.7k | $60k | 40% | Mar 2024 |
|
| California State Teachers Retirement System | 3.7k | $60k | -54% | Mar 2024 |
|
| Tower Research Capital | 3.4k | $55k | 126% | Mar 2024 |
|
| Legal & General Group | 3.3k | $54k | -10% | Mar 2024 |
|
| Aquatic Capital Management | 3.3k | $54k | 100% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 2.1k | $14k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $20k | -70% | Mar 2024 |
|
| Royal Bank of Canada | 837.00 | $0 | -92% | Mar 2024 |
|
| HighMark Wealth Management | 220.00 | $3.6k | 0% | Mar 2024 |
|
| Daiwa Securities Group | 162.00 | $3.0k | 100% | Mar 2024 |
|
| NISA Investment Advisors | 78.00 | $1.3k | 95% | Mar 2024 |
|
| CWM | 66.00 | $999.999000 | 2% | Mar 2024 |
|
| Eagle Bay Advisors | 50.00 | $813.000000 | 0% | Mar 2024 |
|
| GAMMA Investing | 26.00 | $422.999200 | 100% | Mar 2024 |
|
| Russell Investments | 25.00 | $407.000000 | -100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 8.00 | $130.000000 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 1.00 | $16.000000 | 0% | Mar 2024 |
|
Who sold out of Y Mabs Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Dec 2023 | 115k | $783k |
| New York Life Investment Management | Dec 2023 | 69k | $470k |
| Ameriprise Financial | Sep 2023 | 42k | $228k |
| Susquehanna Fundamental Investments | Sep 2023 | 41k | $223k |
| XTX Topco | Sep 2023 | 32k | $173k |
| Algert Coldiron Investors | Sep 2023 | 27k | $145k |
| Mirae Asset Global Investments | Dec 2023 | 26k | $178k |
| Jump Financial | Sep 2023 | 19k | $103k |
| Bailard | Dec 2023 | 17k | $115k |
| Denali Advisors | Dec 2023 | 16k | $112k |
| Cim Investment Mangement | Dec 2023 | 15k | $104k |
| ExodusPoint Capital Management | Sep 2023 | 14k | $77k |
| ADAR1 Capital Management | Dec 2023 | 13k | $89k |
| Lazard Asset Management | Sep 2023 | 12k | $67k |
| Avestar Capital | Dec 2023 | 10k | $68k |
| Point72 Middle East FZE | Dec 2023 | 7.4k | $50k |
| Ohio Pers | Dec 2023 | 5.3k | $36k |
| Simplex Trading | Dec 2023 | 1.6k | $10k |
| IFP Advisors | Sep 2023 | 103.00 | $560.999800 |
| Allspring Global Investments Holdings | Dec 2023 | 46.00 | $312.997800 |